Lou Tartaglia

Lou Tartaglia is the Managing Partner and Co-Founder at Cure Ventures, with a background in biotechnology and lifesciences, specializing in technology transfer and commercialization. With previous roles at Third Rock Ventures and Millennium Pharmaceuticals, Lou has a proven track record in venture capital, corporate development, and clinical development within the pharmaceutical industry. Lou's career highlights include co-founding Cure Ventures and leading investments in companies like Ablexis, showcasing expertise in fostering growth and innovation in the biotech sector. His diverse experience in roles such as CEO at Solstice Biologics and VP at Millennium Pharmaceuticals highlights his strong leadership and strategic vision in the field of drug discovery and development.